News from biodel inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 05, 2012, 16:00 ET

Biodel to Host Analyst / Investor Research and Development Meeting on October 11th in New York

Biodel Inc. (Nasdaq: BIOD) today announced it will be hosting a meeting for analysts and investors on October 11, 2012 in New York. During the...

Sep 27, 2012, 06:00 ET

Biodel to Present at European Association for the Study of Diabetes on October 2, 2012 in Berlin, Germany

 Biodel Inc. (Nasdaq: BIOD) will present experimental data from its ultra-rapid-acting prandial insulin analog program at the 48th annual...

Sep 13, 2012, 06:30 ET

Biodel Announces Phase 2 Clinical Trial Initiation Of Ultra-Rapid-Acting Insulin Candidate BIOD-123

Biodel Inc. (Nasdaq: BIOD) today announced the initiation of a Phase 2 clinical trial of its proprietary recombinant insulin (RHI)-based...

Aug 10, 2012, 06:00 ET

Biodel to Present at 2012 Wedbush PacGrow Lifesciences Management Access Conference

Biodel Inc. (Nasdaq: BIOD) announced today that management will be presenting an overview of the company's technologies, development programs, and...

Jul 26, 2012, 06:00 ET

Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas

 Biodel Inc. (Nasdaq: BIOD) announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health...

Jul 10, 2012, 06:00 ET

Biodel to Present at JMP Securities Healthcare Conference

 Biodel Inc. (Nasdaq: BIOD) announced today that management will be presenting an overview of the Company's technologies, development...

Jun 27, 2012, 06:00 ET

Biodel Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement

Biodel Inc. (Nasdaq: BIOD) announced today that it has received notice from the NASDAQ Stock Market that the Company has regained compliance with...

Jun 22, 2012, 09:15 ET

Biodel Announces $18.5 Million Private Placement

 Biodel Inc. (NASDAQ: BIOD) today announced that it has entered into a definitive securities purchase agreement with a group of...

Jun 08, 2012, 16:01 ET

Biodel Obtains Exclusive License to Aegis Therapeutics' Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations

Biodel Inc. (Nasdaq: BIOD) and Aegis Therapeutics, LLC (Aegis) today announced a partnership providing Biodel an exclusive worldwide license to...

Jun 05, 2012, 06:00 ET

Biodel Announces Data Presentations at American Diabetes Association Annual Meeting

 Biodel Inc. (Nasdaq: BIOD) will present data from animal and human studies with its ultra-rapid-acting prandial insulin product candidates...

May 10, 2012, 15:32 ET

Biodel Announces Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market

Biodel Inc. (Nasdaq: BIOD) today announced that NASDAQ has approved the Company's request to voluntarily transfer the listing of its shares of...

May 10, 2012, 06:00 ET

Biodel Reports Second Quarter Fiscal Year 2012 Financial Results

 Biodel Inc. (Nasdaq: BIOD) today reported financial results for the second fiscal quarter ended March 31, 2012. Highlights since Beginning...

May 07, 2012, 06:00 ET

Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012

 Biodel Inc. (Nasdaq: BIOD) will issue its second quarter fiscal year 2012 financial results on May 10, 2012.  Following the release of...

May 02, 2012, 06:30 ET

Biodel's Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office

Biodel Inc. (Nasdaq: BIOD) announced today that it has received a notice of allowance from the European Patent Office for patent claims covering...

Apr 26, 2012, 16:30 ET

Ms. Julia R. Brown and Mr. Davey S. Scoon Join Biodel Board of Directors

 Biodel Inc. (Nasdaq: BIOD) today announced the appointments of Ms. Julia R. Brown and Mr. Davey S. Scoon to its Board of Directors.  The...

Apr 15, 2012, 20:00 ET

Biodel Reports Positive Top-Line Results from Study of Experimental Ultra-Rapid-Acting Insulin Formulations

 Biodel Inc. (Nasdaq: BIOD) today announced positive top-line results from a Phase 1 clinical trial of its product candidates, BIOD-123 and...

Mar 14, 2012, 16:00 ET

Biodel to Provide Update on Stabilized Glucagon Program at ROTH Conference Today

Biodel Inc. (Nasdaq: BIOD) today will provide an update on its stabilized glucagon program at the ROTH 24th Annual OC Growth Stock...

Mar 08, 2012, 06:00 ET

Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012

 Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Errol De Souza, President and CEO of Biodel, will present a corporate update at the ROTH...

Feb 08, 2012, 16:00 ET

Biodel Reports First Quarter Fiscal Year 2012 Financial Results

Biodel Inc. (Nasdaq: BIOD) today reported financial results for the first quarter ended December 31, 2011. Dr. Errol De Souza, president and...

Feb 03, 2012, 06:59 ET

Biodel to Report First Quarter Fiscal Year 2012 Financial Results on February 8, 2012

 Biodel Inc. (Nasdaq: BIOD) will issue its first quarter fiscal year 2012 financial results on February 8, 2012.  Following the release...